
### [MONDO:0017255](http://purl.obolibrary.org/obo/MONDO_0017255)
**Label:** panuveitis (disease)

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0017258](http://purl.obolibrary.org/obo/MONDO_0017258) (idiopathic panuveitis), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0017211](http://purl.obolibrary.org/obo/MONDO_0017211) (infectious panuveitis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0017261](http://purl.obolibrary.org/obo/MONDO_0017261) (systemic diseases with panuveitis), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0018092](http://purl.obolibrary.org/obo/MONDO_0018092) (Vogt-Koyanagi-Harada disease), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0016206](http://purl.obolibrary.org/obo/MONDO_0016206) (idiopathic uveal effusion syndrome), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), 

**Corr. equiv. classes:** [OMIM:109650](http://purl.obolibrary.org/obo/OMIM_109650), [OMIM:306400](http://purl.obolibrary.org/obo/OMIM_306400), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [OMIM:138990](http://purl.obolibrary.org/obo/OMIM_138990), [OMIM:186580](http://purl.obolibrary.org/obo/OMIM_186580), [Orphanet:3437](http://www.orpha.net/ORDO/Orphanet_3437), [OMIM:613960](http://purl.obolibrary.org/obo/OMIM_613960), [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [Orphanet:279925](http://www.orpha.net/ORDO/Orphanet_279925), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [OMIM:233710](http://purl.obolibrary.org/obo/OMIM_233710), [OMIM:233700](http://purl.obolibrary.org/obo/OMIM_233700), [OMIM:233690](http://purl.obolibrary.org/obo/OMIM_233690), [Orphanet:280933](http://www.orpha.net/ORDO/Orphanet_280933), [Orphanet:280921](http://www.orpha.net/ORDO/Orphanet_280921), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [Orphanet:90340](http://www.orpha.net/ORDO/Orphanet_90340), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [OMIM:609464](http://purl.obolibrary.org/obo/OMIM_609464), [Orphanet:117](http://www.orpha.net/ORDO/Orphanet_117), [Orphanet:209956](http://www.orpha.net/ORDO/Orphanet_209956), [OMIM:233670](http://purl.obolibrary.org/obo/OMIM_233670), 

**Class expressions from DL-Learner:**

- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) 41.02%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 40.36%
- [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 39.17%
- [HP:0002733](http://purl.obolibrary.org/obo/HP_0002733) (Abnormality of the lymph nodes) and [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 38.64%
- [HP:0000988](http://purl.obolibrary.org/obo/HP_0000988) (Skin rash) and [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 38.64%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0002205](http://purl.obolibrary.org/obo/HP_0002205) (Recurrent respiratory infections) 37.21%
- [HP:0000964](http://purl.obolibrary.org/obo/HP_0000964) (Eczema) and [HP:0011947](http://purl.obolibrary.org/obo/HP_0011947) (Respiratory tract infection) 36.78%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 36.10%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 36.07%
- Thing 36.06%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 36.06%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 31.81%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 30.25%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 29.79%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 26.61%


